Merck & Co., Inc. (BIT:1MRKX)

Italy flag Italy · Delayed Price · Currency is EUR
69.10
-0.10 (-0.14%)
At close: May 9, 2025, 5:30 PM CET
-41.54%
Market Cap 169.32B
Revenue (ttm) 59.14B
Net Income (ttm) 16.13B
Shares Out n/a
EPS (ttm) 6.36
PE Ratio 10.50
Forward PE 8.43
Dividend 2.93 (4.24%)
Ex-Dividend Date Mar 14, 2025
Volume 17
Average Volume 184
Open 69.20
Previous Close 69.20
Day's Range 69.10 - 69.70
52-Week Range 67.00 - 126.40
Beta n/a
RSI 35.25
Earnings Date Apr 24, 2025

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janu... [Read more]

Industry Pharmaceutical Preparations
Founded 1891
Employees 75,000
Stock Exchange Borsa Italiana
Ticker Symbol 1MRKX
Full Company Profile

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.